2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Chinese patients with Wilson disease and the treatments: exampled with Unithiol (DMPS) intravenous infusion

X.P. Wang (Shanghai, China)
Chitotriosidase is a biomarker for Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)

S. Hayer, J. Böhringer, L. Schöls (Tübingen, Germany)
Chlorogenic acid exerts anti-neuroinflammatory effect by suppressing NF-κB pathway in Parkinsonian mice model

S. Singh, S. Rai, H. Birla, W. Zahra, S. Singh (Varanasi, India)
Choice for deep brain stimulation in Parkinson’s disease: Italian survey study

R. Ferrucci, C. Di Nuzzo, F. Ruggiero, F. Mancini, A. Priori (Milan, Italy)
Cholinergic basal forebrain and hippocampal structure influence visuospatial function in Parkinson’s disease

R. Berlot, S. Brezovar, B. Koritnik, Z. Pirtošek, N. Ray (Ljubljana, Slovenia)
Chorea and Ataxia as Manifestations of Xeroderma Pigmentosum: A Case Report

A. Jocson, K. Ngo, D. Togasaki, B. Fogel (Los Angeles, CA, USA)
Choreaathetosis as clinical manifestation of Fahr Syndrome inTurner Syndrome Patient

S. Marisdina, M. Mukhlisa, K. Merryn (Palembang, Indonesia)
Chronological view of peak and diphasic dyskinesia, wearing off and freezing in Parkinson’s disease: 1212 Korean population

Y.E. Kim, B. Jeon. (Anyang, Republic of Korea)
Circadian modifications in Parkinson disease

S. Guo (Wuhan, China)
Classification of Dopaminergic-State and Motor Activity by Theta, Beta and Gamma Activity in Parkinson’s Disease

I. Weber, C. Oehrn, N. Apetz, T. Dembek, F. Jung, E. Florin, L. Timmermann (Marburg, Germany)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z